Entheon Biomedical Corp.
ENTBF
$0.00
$0.000.00%
OTC PK
| 05/31/2026 | 02/28/2026 | 11/30/2025 | 08/31/2025 | 05/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 64.60K | 65.30K | 47.60K | 36.40K | 35.80K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 64.60K | 65.30K | 47.60K | 36.40K | 35.80K |
| Operating Income | -64.60K | -65.30K | -47.60K | -36.40K | -35.80K |
| Income Before Tax | 185.10K | -73.10K | -46.60K | -34.30K | -47.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 185.10K | -73.10K | -46.60K | -34.30K | -47.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 185.10K | -73.10K | -46.60K | -34.30K | -47.30K |
| EBIT | -64.60K | -65.30K | -47.60K | -36.40K | -35.80K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 13.86M | 20.61M | 13.86M | 13.86M | 13.86M |
| Average Diluted Shares Outstanding | 13.86M | 20.61M | 13.86M | 13.86M | 13.86M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |